{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Mazzoni E, Frontini F, Rotondo JCharles, Zanotta N, Fioravanti A, Minelli F, Torreggiani E, Campisciano G, Marcuzzi A, Guerra G, Tommasini A, Touz\'e9 A, Martini F, Tognon M, Comar M. Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. J Cell Physiol 2019;234(4):3170-3179.\par \par Bernardi S, Marcuzzi A, Piscianz E, Tommasini A, Fabris B. The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases. Int J Mol Sci 2018;19(12)\par \par Zanotta N, Campisciano G, Scrimin F, Blendi U, Marcuzzi A, Vincenti E, Crovella S, Comar M. Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets. Eur J Obstet Gynecol Reprod Biol 2018;226:66-70.\par \par Marcuzzi A, Loganes C, Valencic E, Piscianz E, Monasta L, Bilel S, Bortul R, Celeghini C, Zweyer M, Tommasini A. Neuronal Dysfunction Associated with Cholesterol Deregulation. Int J Mol Sci 2018;19(5)\par \par Marcuzzi A, Loganes C, Celeghini C, Kleiner G. Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice. Curr Med Chem 2018;25(24):2783-2796.\par \par Loganes C, Lega S, Bramuzzo M, Brumatti LVecchi, Piscianz E, Valencic E, Tommasini A, Marcuzzi A. Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage. Nutrients 2017;9(6)\par \par Marcuzzi A, Piscianz E, Zweyer M, Bortul R, Loganes C, Girardelli M, Baj G, Monasta L, Celeghini C. Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology. Int J Mol Sci 2016;17(3):365.\par \par Marcuzzi A, Vozzi D, Girardelli M, Tricarico PMaura, Knowles A, Crovella S, Vuch J, Tommasini A, Piscianz E, Bianco AMonica. Putative modifier genes in mevalonate kinase deficiency. Mol Med Rep 2016;13(4):3181-9.\par \par Tricarico PMaura, Girardelli M, Kleiner G, Knowles A, Valencic E, Crovella S, Marcuzzi A. Alendronate, a double-edged sword acting in the mevalonate pathway. Mol Med Rep 2015;12(3):4238-42.\par \par Lougaris V, Faletra F, Lanzi G, Vozzi D, Marcuzzi A, Valencic E, Piscianz E, Bianco AM, Girardelli M, Baronio M, Loganes C, Fasth A, Salvini F, Trizzino A, Moratto D, Facchetti F, Giliani S, Plebani A, Tommasini A. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. Clin Immunol 2015;159(1):33-6.\par \par Tricarico PMaura, Piscianz E, Monasta L, Kleiner G, Crovella S, Marcuzzi A. Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency. Apoptosis 2015;20(8):1048-55.\par \par Kleiner G, Zanin V, Monasta L, Crovella S, Caruso L, Milani D, Marcuzzi A. Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1?, interleukin-2 and interleukin-17. Exp Ther Med 2015;9(6):2047-2052.\par \par Marcuzzi A, Piscianz E, Valencic E, Monasta L, Brumatti LVecchi, Tommasini A. To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies. Int J Mol Sci 2015;16(9):21277-93.\par \par Bianco AMonica, Faletra F, Vozzi D, Girardelli M, Knowles A, Tommasini A, Zauli G, Marcuzzi A. Two?gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. Mol Med Rep 2015;12(4):6128-32.\par \par Tricarico PMaura, Kleiner G, Valencic E, Campisciano G, Girardelli M, Crovella S, Knowles A, Marcuzzi A. Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds. Int J Mol Sci 2014;15(4):6843-56.\par \par Brumatti LVecchi, Marcuzzi A, Tricarico PMaura, Zanin V, Girardelli M, Bianco AMonica. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules 2014;19(12):21127-53.\par \par Bianco AMonica, Girardelli M, Vozzi D, Crovella S, Kleiner G, Marcuzzi A. Mevalonate kinase deficiency and IBD: shared genetic background. Gut 2014;63(8):1367-8.\par \par Bianco AMonica, Zanin V, Monasta L, Martelossi S, Marcuzzi A, Crovella S. Family history in early-onset inflammatory bowel disease. J Gastroenterol 2013;48(1):144.\par \par Bianco AMonica, Zanin V, Marcuzzi A, Crovella S. Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. Cell Biochem Funct 2012;30(2):176.\par \par Vuch J, Marcuzzi A, Zanin V, Crovella S. Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. Toxicology 2012;293(1-3):123-4.\par \par Bianco AMonica, Zanin V, Girardelli M, Magnolato A, Martelossi S, Martellossi S, Tommasini A, Marcuzzi A, Crovella S. A common genetic background could explain early-onset Crohn's disease. Med Hypotheses 2012;78(4):520-2.\par \par Zanin V, Marcuzzi A, Piscianz E, Vuch J, Bianco AMonica, Monasta L, Decorti G, Crovella S. The effect of clodronate on a mevalonate kinase deficiency cellular model. Inflamm Res 2012;61(12):1363-7.\par \par Marcuzzi A, Girardelli M, Bianco AMonica, Martelossi S, Magnolato A, Tommasini A, Crovella S. Inflammation profile of four early onset Crohn patients. Gene 2012;493(2):282-5.\par \par Marcuzzi A, Zanin V, Piscianz E, Tricarico PMaura, Vuch J, Girardelli M, Monasta L, Bianco AMonica, Crovella S. Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. Int J Dev Neurosci 2012;30(6):451-6.\par \par Marcuzzi A, Crovella S, Monasta L, Brumatti LVecchi, Gattorno M, Frenkel J. Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. Curr Pharm Des 2012;18(35):5746-52.\par \par Tricarico PMaura, Marcuzzi A, Zanin V, Kleiner G, Bianco AMonica, Crovella S. Serum amyloid A and cholesterol: a pivotal role on inflammation. Amyloid 2012;19(3):163-4; author reply 165-6.\par \par Zanin V, Delbue S, Marcuzzi A, Tavazzi E, Del Savio R, Crovella S, Marchioni E, Ferrante P, Comar M. Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. J Neurovirol 2012;18(5):416-22.\par \par Marcuzzi A, Secchiero P, Crovella S, Zauli G. TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. Cytokine 2012;60(1):43-6.\par \par Marcuzzi A, Zanin V, Crovella S, Pontillo A. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). Oral Oncol 2011;47(5):436-7; author reply 438.\par \par Marcuzzi A, De Leo L, Decorti G, Crovella S, Tommasini A, Pontillo A. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res 2011;70(1):78-82.\par \par Marcuzzi A, Crovella S, Pontillo A. Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In Vivo 2011;25(1):87-92.\par \par Marcuzzi A, Zanin V, Vuch J, Pontillo A, Crovella S. Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. J Korean Med Sci 2011;26(6):848-9; author reply 850.\par \par Marcuzzi A, Decorti G, Pontillo A, Ventura A, Tommasini A. Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. Inflamm Res 2010;59(5):335-8.\par \par Marcuzzi A, Tommasini A, Crovella S, Pontillo A. Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. Int Immunopharmacol 2010;10(6):639-42.\par \par De Leo L, Marcuzzi A, Decorti G, Tommasini A, Crovella S, Pontillo A. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 2010;61(6):506-10.\par \par }